Technology and certifications

INNOVATIVE TECHNOLOGY: SaltMed Dry Salt Inhaler using an unique process to produce dry saline aerosols, at optimal therapeutic size!

The SaltMed inhaler device generates dry salt aerosols with salt particles between 0.3 – 5 microns and has been shown to have significant therapeutic benefits in the treatment of respiratory conditions such as: Acute Bronchitis, Allergic Rhinitis, Bronchiolitis, Asthma, COPD, Cough, Cystic Fibrosis and several other ENT conditions.

SaltMed inhaler uses an innovative mechanical erosion process based on the forced passing of air through a complex structured dry salt cartridge.

SaltMed devices are delivered with an L-type cartridge recommended for home, which can be used up to 60 hours. There are also available the N-type cartridge which can be used up to 100 hours and the Forte-type cartridge, which can be used up to 50 hours. N-type and Forte-type cartridges are primarily recommended for being used in medical facilities and intensive use, respectively.

The SaltMed -Dry salt Inhaler “INx-SM’ (Fig. 1) includes the salt cartridge ‘Cx-SM’, an Aerosol mask, Air pump ‘PP-SM’ (fig. 1A- RESUN, fig. 1B- AQUAEL) and Oxygen Tubing packed in a carton box. The air pump is connected to the cartridge with the flexible oxygen tube.

Fig. 1A

Fig. 1B

Fig. 1 – Dry salt inhaler - Saltmed

A: Cx-SM, Salt cartridge;

B: Aerosol mask (separate device);

C: PP-SM, Air pump;

D: Oxygen tube (separate device);

E: Cartridge storage container.

SaltMed cartridge ‘Cx-SM’

It is supplied in a special storage container (Fig. 2) which includes in its lower section silica-gel, a drying agent to absorb humidity.

SaltMed cartridges should always be stored in their containers when not in use, to maintain the efficacy. It is important to keep the SaltMed cartridge dry. If the air humidity exceeds 65% due to inadequate cartridge storage, blockage of the salt layer will occur and lead to a loss in therapeutic effect.

Fig. 2 – Boiling movement

Fig. 3 – The SaltMed cartridge in its storage container

1 – Container cover

2 – Storage container

3 – Upper cover of cartridge

4 – NaCl grain layer

5 – NaCl micro-crystals layer

6 – Connector (tube to air pump)

7 – Container sieves

8 – Silica-gel

During use, air from the pump passes through the microcrystalline layer in the lower part of the cartridge and will create the visible appearance of a ‘boiling’ movement (Fig. 2). The air under pressure erodes the salt micro-crystals and generates dry salt particles between 0.3-5 microns.

The highly concentrated active salt particles, optimally sized between 0.3 and 5 microns are inhaled into the respiratory tract. They are dissolved in the mucus layer covering the airway epithelium and attract water from interstitial tissue into the airways. As a result, inflammation is reduced and hydration of the mucus increases. Reduction of local inflammation improves the symptoms related to airway obstruction and inflammation (such as nasal obstruction, sinus pressure, local pain). Respiratory secretions fluidisation improves the mucus removal and alleviates the stress of an exhausting dry cough by changing it into a productive cough.

Additionally, dry salt aerosols increase protection against respiratory infections and provide anti- inflammatory, immune-modulating and desensitization effects which are very important in allergic respiratory diseases (asthma, allergic rhinitis).

Consequences of these effects: the SaltMed Inhaler assists over time to an elimination of respiratory episodes of infectious (cold, flu) or allergic (allergic rhinitis, asthma) diseases. A reduction in relapses and acute exacerbations in chronic patients may also occur.

Find out how to use the saline inhaler SaltMed in chronic bronchitis (COPD), persistent cough, bronchiolitis (wheezing), sinusitis, hay fever, asthma, as well as preventing respiratory diseases!

Certifications and clinical trials

• The product SaltMed® is a Medical device therapeutically active (in accordance with Council Directive 93/42/EEC)
• SaltMed® is certified in the European Community (CE mark)
• The efficacy and safety of therapy with SaltMed® have been proven through clinical medical studies:
  • Study of acute respiratory failure UPU section Floreasca Emergency hospital Bucharest
  • Inhaled dry salt micro particles in the treatment of bronchopulmonary dysplasia - “Marie Curie” Emergency Hospital for Children
  • The Use of the Individual Saline Inhaler “Saltmed®” In Patients In Critical Condition with Acute Respiratory Failure Case Report
  • Declaration of conformity